Sivakumar Loganathan to Protein Kinase Inhibitors
This is a "connection" page, showing publications Sivakumar Loganathan has written about Protein Kinase Inhibitors.
Connection Strength
0.596
-
Tyrosine Kinase Inhibitors (TKIs) in Lung Cancer Treatment: A Comprehensive Analysis. Curr Cancer Drug Targets. 2021; 21(1):55-69.
Score: 0.581
-
Protein kinase C beta in malignant pleural mesothelioma. Anticancer Drugs. 2008 Oct; 19(9):841-8.
Score: 0.016